1. Comorbidities of pyoderma gangrenosum: a retrospective multicentric analysis of 126 patients. (15th May 2018) Authors: Gillard, M.; Anuset, D.; Maillard, H.; Senet, P.; Cuny, J. F.; Mahe, E.; Sin, C.; Dessiner, F.; Goujon, E.; Journet‐Tollhupp, J.; Debure, C.; Dabouz, F.; Develter, T.; Bernard, P.; Lok, C.; Modiano, P. Journal: British journal of dermatology Issue: Volume 179:Number 1(2018) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comorbidities of pyoderma gangrenosum: a retrospective multicentric analysis of 126 patients. (1st July 2018) Authors: Gillard, M.; Anuset, D.; Maillard, H.; Senet, P.; Cuny, J. F.; Mahe, E.; Sin, C.; Dessiner, F.; Goujon, E.; Journet‐Tollhupp, J.; Debure, C.; Dabouz, F.; Develter, T.; Bernard, P.; Lok, C.; Modiano, P. Journal: British journal of dermatology Issue: Volume 179:Number 1(2018) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lookalike and soundalike drugs: a potential cause of cutaneous adverse reactions to drugs. (1st September 2019) Authors: Cassius, C.; Davis, C.J.; Bravard, P.; Carre‐Gislard, D.; Modiano, P.; Lebrun‐Vignes, B.; Ingen‐Housz‐Oro, S.; Chosidow, O. Journal: British journal of dermatology Issue: Volume 181:Number 3(2019) Page Start: 626 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. One‐year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate‐to‐severe plaque psoriasis. (1st February 2014) Authors: Reich, K.; Puig, L.; Paul, C.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J.‐F.; Rizova, E.; Brunori, M.; Mistry, S.; Bergmans, P.; Barker, J.; Adamski, Z.; Altomare, G.; Aricò, M.; Aste, N.; Aubin, F.; Augustin, M. Journal: British journal of dermatology Issue: Volume 170:Number 2(2014:Feb.) Page Start: 435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Transition to ustekinumab in patients with moderate‐to‐severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT). (1st February 2014) Authors: Paul, C.; Puig, L.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J.‐F.; Rizova, E.; Lavie, F.; Mistry, S.; Bergmans, P.; Barker, J.; Reich, K.; Adamski, Z.; Altomare, G.; Aricò, M.; Aste, N.; Aubin, F.; Augustin, M. Journal: British journal of dermatology Issue: Volume 170:Number 2(2014:Feb.) Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lookalike and soundalike drugs: a potential cause of cutaneous adverse reactions to drugs. (18th June 2019) Authors: Cassius, C.; Davis, C.J.; Bravard, P.; Carre‐Gislard, D.; Modiano, P.; Lebrun‐Vignes, B.; Ingen‐Housz‐Oro, S.; Chosidow, O. Journal: British journal of dermatology Issue: Volume 181:Number 3(2019) Page Start: 626 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Monitoring of topical corticosteroid phobia in a population of parents with children with atopic dermatitis using the TOPICOP® scale: prevalence, risk factors and the impact of therapeutic patient education. (30th September 2016) Authors: Gonzales, F.; Ramdane, N.; Delebarre‐Sauvage, C.; Modiano, P.; Duhamel, A.; Lasek, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 3(2017) Page Start: e172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Factors associated with the choice of the first biologic in psoriasis: real‐life analysis from the Psobioteq cohort. (16th July 2017) Authors: Sbidian, E.; Giboin, C.; Bachelez, H.; Paul, C.; Beylot‐Barry, M.; Dupuy, A.; Viguier, M.; Lacour, J.‐P.; Schmutz, J.‐L.; Bravard, P.; Mahé, E.; Beneton, N.; Misery, L.; Delaporte, E.; Modiano, P.; Barbarot, S.; Regnier, E.; Jullien, D.; Richard, M.‐A.; Joly, P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 12(2017) Page Start: 2046 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Transition to ustekinumab in patients with moderate‐to‐severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT). (February 2014) Authors: Paul, C.; Puig, L.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J.‐F.; Rizova, E.; Lavie, F.; Mistry, S.; Bergmans, P.; Barker, J.; Reich, K.; Adamski, Z.; Altomare, G.; Aricò, M.; Aste, N.; Aubin, F.; Augustin, M. Journal: British journal of dermatology Issue: Volume 170:Number 2(2014:Feb.) Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. One‐year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate‐to‐severe plaque psoriasis. (February 2014) Authors: Reich, K.; Puig, L.; Paul, C.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J.‐F.; Rizova, E.; Brunori, M.; Mistry, S.; Bergmans, P.; Barker, J.; Adamski, Z.; Altomare, G.; Aricò, M.; Aste, N.; Aubin, F.; Augustin, M. Journal: British journal of dermatology Issue: Volume 170:Number 2(2014:Feb.) Page Start: 435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗